CTCBIO Inc. (KOSDAQ:060590)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,440.00
-30.00 (-0.67%)
At close: Jan 29, 2026

CTCBIO Revenue

CTCBIO had revenue of 31.80B KRW in the quarter ending September 30, 2025, a decrease of -11.16%. This brings the company's revenue in the last twelve months to 132.76B, down -4.46% year-over-year. In the year 2024, CTCBIO had annual revenue of 144.41B with 4.74% growth.

Revenue (ttm)
132.76B
Revenue Growth
-4.46%
P/S Ratio
0.80
Revenue / Employee
535.32M
Employees
248
Market Cap
106.15B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024144.41B6.53B4.74%
Dec 31, 2023137.88B-27.33B-16.54%
Dec 31, 2022165.21B24.89B17.74%
Dec 31, 2021140.32B10.29B7.91%
Dec 31, 2020130.03B-6.09B-4.48%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
KoBioLabs71.83B
Cell Biotech50.65B
Choong Ang Vaccine Laboratory39.19B
Naturalendo Tech21.87B
BIO-FD&C18.82B
TegoScience6.15B
Quratis2.28B
Progen450.00M
Revenue Rankings